Calumet Specialty Products Partners L.P. (NASDAQ:CLMT) traded today at a new 52-week high of $16.30. This new high was reached on below average trading volume as 129,000 shares traded hands, while the average 30-day volume is approximately 208,000 shares.
Calumet Specialty Products Partners L.P. (NASDAQ:CLMT) is currently priced 48.1% above its average consensus analyst price target of $8.37.
Over the past year, Calumet Specialty Products Partners L.P. has traded in a range of $2.96 to $16.30 and is now at $16.13, 445% above that low.
Calumet Specialty Products Partners LP is an independent producer of specialty hydrocarbon products in North America. The company operates through three segments namely Specialty products which process crude oil and other feedstocks into a variety of customized lubricating oils, white mineral oils, solvents, petrolatum's and waxes; the Fuel products segments which processes crude oil into a variety of fuel and fuel-related products, including gasoline, diesel, jet fuel, asphalt and heavy fuel oils and Corporate segment.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About IBN (InvestorBrandNetwork)
IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.
For more information on IBN, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer